Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AMSF vs ADUS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ADUS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

ADUS Overall Winner 6-Pillar Tally: AMSF 2 – 4 ADUS Matrix Metrics: AMSF 5 – 5 ADUS

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over AMERISAFE, Inc. (AMSF) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). AMSF carries a Unified Composite Score of 55.6/100 (HOLD) at $18.87 (10.1x Forward P/E, 15.0% operating margin), whereas ADUS carries 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin).

  • Technical & Structure Timing Caution: AMSF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.9); meanwhile ADUS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMSF vs ADUS
AMSF NASDAQ
AMERISAFE, Inc.
Fire, Marine & Casualty Insurance
$18.87
-0.16% 1D
Market Cap $350.3M
TTM Revenue $333M
Forward P/E 10.1x
Beta / 30D Vol -0.21β · 44% Vol
Unified Composite Score
55.6 / 100 HOLD
Tech 73.0 Fund 65.0 Flow 63.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.2%), weak momentum, RSI 23
RSI-14: 22.9 · SMA20: $20.80 · SMA50: $23.06
ADUS NASDAQ Head-to-Head Winner
Addus HomeCare Corp.
Services-Home Health Care Services
$122.50
+1.18% 1D
Market Cap $2.3B
TTM Revenue $1.50B
Forward P/E 16.1x
Beta / 30D Vol -0.07β · 21% Vol
Unified Composite Score
59.0 / 100 HOLD
Tech 57.0 Fund 52.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 52
RSI-14: 51.6 · SMA20: $123.87 · SMA50: $118.74

6-Pillar Scorecard Institutional Category Breakdown (AMSF 2 – 4 ADUS)

Columns: Metric · AMSF · ADUS
1. Valuation Multiples AMSF
Forward P/E 10.1x 16.1x
Trailing P/E 8.8x 20.1x
PEG Ratio 1.81x 1.05x
EV / Revenue 1.1x 1.5x
2. Growth & Scale ADUS
Revenue Growth (YoY) -2.6% +7.0%
Earnings Growth (YoY) -46.0% +24.2%
TTM Revenue (USD) $333M $1.50B
Market Cap $350.3M $2.3B
3. Profitability & Quality AMSF
Gross Margin 25.5% 32.3%
Operating Margin 15.0% 10.4%
Net Profit Margin 12.1% 7.4%
Return on Equity (ROE) 15.8% 10.0%
4. Balance Sheet & Cash Flow ADUS
Cash Generation (TTM) $12M $173M EBITDA
Cash Flow Margin 3.7% 11.5% EBITDA Mgn
Net Cash / Leverage $12.81 Book/Sh · 15.8% ROE $64.64 Book/Sh · 10.0% ROE
Dividend Yield 8.56% None (0.00%)
5. Options & Positioning ADUS
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 26.2% (15th %ile) 21.9% (16th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat ADUS
OpEx & R&D Intensity 10.5% of Rev ($35M) 21.9% of Rev ($329M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Specialty Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMSF (5) vs ADUS (5)
Institutional Metric AMSF ADUS Criterion Row Edge
Market Capitalization
Scale
$350.3M $2.3B Larger Scale ADUS
Trailing P/E Ratio
Valuation
8.8x 20.1x Lower Multiple AMSF
Forward P/E Ratio
Valuation
10.1x 16.1x Lower Multiple AMSF
Revenue Growth (YoY)
Growth
-2.6% +7.0% Higher Growth ADUS
Operating Margin (TTM)
Profitability
15.0% 10.4% Higher Margin AMSF
Net Profit Margin
Profitability
12.1% 7.4% Higher Margin AMSF
Return on Equity (ROE)
Capital Efficiency
15.8% 10.0% Higher ROE AMSF
52-Week Range Position
Momentum
1% ($19–$42) 79% ($88–$132) Stronger Trend ADUS
Beta / 30D Volatility
Risk Regime
-0.21β · 44% Vol -0.07β · 21% Vol Lower Realized Risk ADUS
Unified Institutional Score
Composite Signal
55.6 / 100 (HOLD) 59.0 / 100 (HOLD) Higher Composite ADUS
Trailing 12M Revenue (USD)
Operating Scale
$333M $1.50B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
25.5% 32.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.81x PEG · 1.1x EV/Rev 1.05x PEG · 1.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$12M ($12.81 Book/Sh · 15.8% ROE) $173M EBITDA ($64.64 Book/Sh · 10.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ADUS +28.87 pp
AMSF: -29.01% · ADUS: -0.14%
3M Horizon ADUS +29.95 pp
AMSF: -28.56% · ADUS: +1.39%
6M Horizon ADUS +71.45 pp
AMSF: -39.23% · ADUS: +32.22%
1Y Horizon ADUS +65.62 pp
AMSF: -53.23% · ADUS: +12.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMSF vs ADUS. Trailing 12-month operating profitability (AMSF 15.0% vs ADUS 10.4%) and valuation multiples (AMSF 10.1x vs ADUS 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.

AMSF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$333M
Gross Margin25.5%
Op. Margin15.0%
ROE / Fwd P/E15.8% · 10.1x
ADUS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.50B
Gross Margin32.3%
Op. Margin10.4%
ROE / Fwd P/E10.0% · 16.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMSF BREAKDOWN
97d in phase · OBV NEUTRAL
Current IV 26.2%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact AMSF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ADUS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 21.9%
IV Percentile 16th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ADUS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMSF Moat Profile Scale & Operating Efficiency Moat
Insurance - Specialty Operator
Competes within the Insurance - Specialty value chain with $350.3M market capitalization and 15.0% operating margin.
OpEx & R&D Reinvestment 10.5% of Rev ($35M)
90D Engineering Disclosures 0 Published
ADUS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $2.3B market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 21.9% of Rev ($329M)
90D Engineering Disclosures 0 Published

Investor FAQ AMSF vs ADUS Key Questions & Quantitative Answers

As of Nov 20, 2026, Addus HomeCare Corp. (ADUS) is the stronger overall head-to-head candidate over AMERISAFE, Inc. (AMSF) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). AMSF carries a Unified Composite Score of 55.6/100 (HOLD) at $18.87 (10.1x Forward P/E, 15.0% operating margin), whereas ADUS carries 59.0/100 (HOLD) at $122.50 (16.1x Forward P/E, 10.4% operating margin). Technical & Structure Timing Caution: AMSF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.9); meanwhile ADUS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ADUS leads the Growth & Scale pillar: AMSF posts -2.6% YoY revenue growth and -46.0% YoY earnings growth on $333M TTM revenue (25.5% gross margin, 15.0% operating margin), compared with ADUS at +7.0% YoY revenue growth and +24.2% YoY earnings growth on $1.50B TTM revenue (32.3% gross margin, 10.4% operating margin). On trailing 12-month operating scale, AMSF generates $333M in USD-normalized revenue versus $1.50B for ADUS. In operating R&D and SG&A reinvestment, AMSF deploys 10.5% of Rev ($35M) (0 90-day corporate R&D disclosures) versus 21.9% of Rev ($329M) (0 disclosures) for ADUS.

AMSF screens cheaper on headline valuation multiples. AMSF trades at 10.1x Forward P/E, 8.8x Trailing P/E, 1.81x PEG, and 1.1x EV/Revenue (3.7% FCF margin), whereas ADUS trades at 16.1x Forward P/E, 20.1x Trailing P/E, 1.05x PEG, and 1.5x EV/Revenue (11.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMSF (15.8% ROE) versus ADUS (10.0% ROE) capital efficiency.

In options market volatility and institutional positioning, AMSF carries 26.2% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-0.21β · 44% Vol realized risk). By comparison, ADUS carries 21.9% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.07β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.